The relationship between Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Monocyte to Lymphocyte Ratio (MLR) with the clinical severity level of COVID-19 patients at Udayana University Hospital
DOI:
https://doi.org/10.33448/rsd-v13i9.46864Keywords:
COVID-19; Clinical severity level; Monocyte to lymphocyte ratio; Neutrophil to lymphocyte ratio; Platelet to lymphocyte ratio.Abstract
Background: COVID-19 is an pandemic with a high transmission rate. Due to its widespread availability, complete blood count has the potential to be used as an initial screening for clinical severity. Objective: This study aims to determine the relationship between NLR, PLR, and MLR with the clinical severity level of patients with COVID-19. Method: A cross-sectional study was conducted at Udayana University Hospital on COVID-19 patients hospitalized from March 2020 to March 2021. Subjects were divided into critical and non-critical groups and analyzed for their relationship with the components of the complete blood count on the first day of hospitalization. Result: The analysis found that the study subjects had a mean (± standard deviation) age of 54.20 (± 15.57) years. The mean (± SD) hemoglobin level was found to be 13.44 (± 4.05) g/dL, and the platelet count was 245.75 (± 107.36) x 103/μL. The median (interquartile range) leukocyte count was found to be 7.78 (4.91) x 103/μL, neutrophils 5.72 (4.91) x 103/μL, basophils 0.01 (0.01) x 103/μL, eosinophils 0.01 (0.01) x 103/μL, monocytes 0.53 (0.41) x 103/μL, lymphocytes 1.10 (0.89) x 103/μL, NLR 5.21 (7.77), PLR 193.34 (153.54), and MLR 0.51 (0.42). Conclusion: NLR, PLR, and MLR are significantly associated with the clinical severity level in COVID-19 patients at Udayana University Hospital. These findings can assist clinicians in assessing the potential for worsening clinical severity from mild to severe or critical levels in COVID-19 patients.
References
Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2020). Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad. Clinical Rheumatology, 39(9), 2529–2543. https://doi.org/10.1007/s10067-020-05275-1
Bellan, M., Azzolina, D., Hayden, E., Gaidano, G., Pirisi, M., Acquaviva, A., Aimaretti, G., Aluffi Valletti, P., Angilletta, R., Arioli, R., Avanzi, G. C., Avino, G., Balbo, P. E., Baldon, G., Baorda, F., Barbero, E., Baricich, A., Barini, M., Barone-Adesi, F., & Sainaghi, P. P. (2021). Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19. Disease Markers, 2021, 1–7. https://doi.org/10.1155/2021/8863053
COVID-19 Traveler Policy in Migrant Worker: How it Helped Shape Distinct Clusters During the Early Phases of the Pandemic. (n.d.).
Fors, M., Ballaz, S., Ramírez, H., Mora, F. X., Pulgar-Sánchez, M., Chamorro, K., & Fernández-Moreira, E. (2022). Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.822556
Gallo Marin, B., Aghagoli, G., Lavine, K., Yang, L., Siff, E. J., Chiang, S. S., Salazar-Mather, T. P., Dumenco, L., Savaria, M. C., Aung, S. N., Flanigan, T., & Michelow, I. C. (2021). Predictors of COVID-19 severity: A literature review. Reviews in Medical Virology, 31(1), 1–10. https://doi.org/10.1002/rmv.2146
Harkitasari, S., Sumardika, I. W., Purnamasidhi, C. A. W., Adiputra, I. K. H., Purnama, G. V., & Suteja, R. C. (2023). Autologous Platelet-Rich Plasma: A Potential Therapy to Mitigate Severe Covid-19 Manifestations. Biomedical and Pharmacology Journal, 16(3), 1663–1667. https://doi.org/10.13005/bpj/2744
Junqueira, C., Crespo, Â., Ranjbar, S., de Lacerda, L. B., Lewandrowski, M., Ingber, J., Parry, B., Ravid, S., Clark, S., Schrimpf, M. R., Ho, F., Beakes, C., Margolin, J., Russell, N., Kays, K., Boucau, J., Das Adhikari, U., Vora, S. M., Leger, V., & Lieberman, J. (2022). FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature, 606(7914), 576–584. https://doi.org/10.1038/s41586-022-04702-4
Kumar, A., Narayan, R. K., Kumari, C., Faiq, M. A., Kulandhasamy, M., Kant, K., & Pareek, V. (2020). SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Medical Hypotheses, 145, 110320. https://doi.org/10.1016/j.mehy.2020.110320
Nahian, A., Suteja, R. C., Shellah, D., Egan, C., Găman, M.-A., & Bonilla-Escobar, F. J. (2022). The State of Learning Patterns within Medical Education in a Post-pandemic World: Reflection from IJMS Authors and an Overview of the IJMS Volume 10 Issue 3. International Journal of Medical Students, 10(3), 233–235. https://doi.org/10.5195/ijms.2022.1695
Park, M., Cook, A. R., Lim, J. T., Sun, Y., & Dickens, B. L. (2020). A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. Journal of Clinical Medicine, 9(4), 967. https://doi.org/10.3390/jcm9040967
Purnamasidhi, C. A. W., Januraga, P. P., Sukmawati, N. M. D. D., Gayatri, A. A. A. Y., Utama, I. M. S., Somia, I. K. A., Merati, K. T. P., Suteja, R. C., & Purnama, G. V. (2023). The Impact of Vaccination to Clinical Severity and Mortality of COVID-19 Patients. Bali Journal of Anesthesiology, 7(1), 3–7. https://doi.org/10.4103/bjoa.bjoa_268_22
Purnamasidhi, C. A. W., Suteja, R. C., Adiputra, I. K. H., Purnama, G. V., Mulyantari, N. K., & Somia, I. K. A. (2021). A comparison of antigen-based rapid test and RT-PCR test to diagnose COVID-19 and its infectivity. Romanian Medical Journal, 68(August), 399–405. https://doi.org/10.37897/RMJ.2021.3.11
Putu Kintan Wulandari, Richard Christian Suteja, I Gede Purna Weisnawa, Jerry, I Komang Hotra Adiputra, Giovanca Verentzia Purnama, Darren Junior, Dewa Ayu Fony Prema Shanti, & Cokorda Agung Wahyu Purnamasidhi. (2022). Adverse Effects of Third-Dose Moderna Vaccination for Healthcare Workers of Udayana University Hospital, Bali, Indonesia. International Journal of Medical Students. https://doi.org/10.5195/ijms.2022.1773
Rahman, T., Khandakar, A., Hoque, M. E., Ibtehaz, N., Kashem, S. Bin, Masud, R., Shampa, L., Hasan, M. M., Islam, M. T., Al-Maadeed, S., Zughaier, S. M., Badran, S., Doi, S. A. R., & Chowdhury, M. E. H. (2021). Development and Validation of an Early Scoring System for Prediction of Disease Severity in COVID-19 Using Complete Blood Count Parameters. IEEE Access, 9, 120422–120441. https://doi.org/10.1109/ACCESS.2021.3105321
Sastroasmoro, S., & Ismael, S. (1995). Dasar-Dasar Metodologi Penelitian Klinis (4th ed.). Sagung Seto.
Seyit, M., Avci, E., Nar, R., Senol, H., Yilmaz, A., Ozen, M., Oskay, A., & Aybek, H. (2021a). Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. The American Journal of Emergency Medicine, 40, 110–114. https://doi.org/10.1016/j.ajem.2020.11.058
Seyit, M., Avci, E., Nar, R., Senol, H., Yilmaz, A., Ozen, M., Oskay, A., & Aybek, H. (2021b). Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. The American Journal of Emergency Medicine, 40, 110–114. https://doi.org/10.1016/j.ajem.2020.11.058
Simadibrata, D. M., Pandhita, B. A. W., Ananta, M. E., & Tango, T. (2022a). Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis. Journal of the Intensive Care Society, 23(1), 20–26. https://doi.org/10.1177/1751143720969587
Simadibrata, D. M., Pandhita, B. A. W., Ananta, M. E., & Tango, T. (2022b). Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis. Journal of the Intensive Care Society, 23(1), 20–26. https://doi.org/10.1177/1751143720969587
Sumardika, I. W., Purnamasidhi, C. A. W., Darwinata, A. E., Purnama, G. V., Jerry, J., Adiputra, I. K. H., Suteja, R. C., & Weisnawa, I. G. P. (2021). Molnupiravir: a novel efficacious antiviral candidate to COVID-19. Research, Society and Development, 10(15), e281101423014. https://doi.org/10.33448/rsd-v10i15.23014
Suteja, R. C., Purnamasidhi, C. A. W., Krisnawardani K, C. I. Y., & Suastika, L. O. S. (2023). Hubungan Komponen Dalam Pemeriksaan Darah Lengkap Terhadap Tingkat Keparahan Klinis Pasien Covid-19 Di Rumah Sakit Universitas Udayana. E-Jurnal Medika Udayana, 12(10), 42. https://doi.org/10.24843/mu.2023.v12.i10.p08
Suteja, R., Novianti, P., Dewi, K., Widiyanti, E., Wijayanti, I., K, C., & Purnamasidhi, C. (2020). Migrant Workers of Indonesia: Transmission Channels of SARS-CoV-2 Amidst COVID-19 Pandemic in Indonesia. International Journal of Medical Reviews and Case Reports, 4(0), 1. https://doi.org/10.5455/ijmrcr.2020-05-197
Vafadar Moradi, E., Teimouri, A., Rezaee, R., Morovatdar, N., Foroughian, M., Layegh, P., Rezvani Kakhki, B., Ahmadi Koupaei, S. R., & Ghorani, V. (2021a). Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. The American Journal of Emergency Medicine, 40, 11–14. https://doi.org/10.1016/j.ajem.2020.12.003
Vafadar Moradi, E., Teimouri, A., Rezaee, R., Morovatdar, N., Foroughian, M., Layegh, P., Rezvani Kakhki, B., Ahmadi Koupaei, S. R., & Ghorani, V. (2021b). Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. The American Journal of Emergency Medicine, 40, 11–14. https://doi.org/10.1016/j.ajem.2020.12.003
Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J., & Jiang, H. (2020). Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. Journal of Infection, 80(6), 639–645. https://doi.org/10.1016/j.jinf.2020.03.019
Weisnawa, I. G. P., Susilawathi, N. M., Purnamasidhi, C. A. W., Purnama, G. V., Adiputra, I. K. H., Suteja, R. C., Jerry, J., & Wulandari, P. K. (2022). Anosmia as a clinical predictor to non-fatal COVID-19 case and better survivability. Research, Society and Development, 11(2), e14811224661. https://doi.org/10.33448/rsd-v11i2.24661
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Cokorda Agung Wahyu Purnamasidhi; I Gede Vendi Cahyadi Riandika; Ni Made Dewi Dian Sukmawati; Anak Agung Ayu Yuli Gayatri; I Made Susila Utama; I Ketut Agus Somia; Ketut Tuti Parwati Merati
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.